Cyclic estradiol treatment phasically potentiates endogenous cholecystokinin's satiating action in ovariectomized rats.
The influence of ovarian cycling and of exogenous estradiol on the cholecystokinin (CCK) satiety-signalling system was investigated in intact and ovariectomized Long-Evans rats, respectively. Intraperitoneal injection of 1 mg/kg devazepide, the most potent and selective CCK(A) receptor antagonist, increased test meal size during estrus, but not during diestrus, confirming the influence of hypothalamic-pituitary-gonadal function on CCK satiety in intact rats. Devazepide was then tested in ovariectomized rats that received chronic cyclic estradiol (2 microg estradiol benzoate on Tuesday and Wednesday each week) or oil treatment. Devazepide did not increase meal size in estradiol-treated rats on Tuesday, prior to estradiol treatment, compared to oil-treated rats, but did selectively increase meal size on Friday, late in the estradiol replacement cycle, compared to Tuesday, early in the cycle. These results suggest that a phasic potentiation of the endogenous CCK satiety-signalling system is part of the mechanism for the decrease in meal size in female rats during estrus.
Asarian
L
L
Department of Psychiatry, Joan and Sandford I. Weill Medical College of Cornell University, New York Presbyterian Hospital, Westchester Division, White Plains 10605, USA.
Geary
N
N
D000818:Animals; D002766:Cholecystokinin / Q000502:physiology*; D020109:Devazepide / Q000008:administration & dosage; D004347:Drug Interactions; D004958:Estradiol / Q000008:administration & dosage*; D015914:Estrogen Replacement Therapy; D005247:Feeding Behavior / Q000502:physiology; D005260:Female; D006727:Hormone Antagonists / Q000008:administration & dosage; D007030:Hypothalamo-Hypophyseal System / Q000502:physiology*; D008597:Menstrual Cycle / Q000502:physiology; D010052:Ovariectomy; D010053:Ovary / Q000502:physiology*; D010507:Periodicity; D051381:Rats; D020318:Rats, Long-Evans; D043886:Receptor, Cholecystokinin A; D011949:Receptors, Cholecystokinin / Q000037:antagonists & inhibitors; D012527:Satiation / Q000502:physiology*
D006727:Hormone Antagonists; D043886:Receptor, Cholecystokinin A; D011949:Receptors, Cholecystokinin; D004958:Estradiol; D002766:Cholecystokinin; D020109:Devazepide